Arrowhead Research Corp.
Arrowhead Research Corporation is a holding company that forms, acquires, and operates portfolio companies commercializing innovative nanotechnologies. By working closely with leading scientists and universities, Arrowhead identifies the latest advances in nanotechnology and matches them with product development opportunities in high-growth markets. The Company is currently focused on the electronics and biotech industries.
Arrowhead takes an active role in their development, keeping the business and technical development teams at the portfolio level focused on near term revenue opportunities and capital efficiency.
Arrowhead’s strategy is to maintain or build a majority ownserhip position in each portfolio company, thus providing significant exposure to their growth. Arrowhead’s ultimate goal is to monetize the value of its subsidiaries through an initial public offering of subsidiary stock or a sale of a subsidiary to another company. Alternatively, Arrowhead could retain ownership of subsidiary to capture its continuing cash flow and income. Arrowhead is currently focused on its two majority-owned subsidiaries, Unidym, Inc.
Contact Details
Office Address
Arrowhead Research Corp.
201 South Lake Avenue
Suite 703
Pasadena, CA, USA 91101
Phone: (626) 304-3400
Fax: (626) 304-3401
Executives
Founder, Exec. Chairman, Director of Aonex, Director of Unidym of Insert Therapeutics Inc
Mr. R. Bruce Stewart
Chief Exec. Officer, Pres, Director, Chief Exec. Officer of Calando, Chief Exec. Officer of Tego, Chief Exec. Officer of Unidym, Chief Exec. Officer of Nantope and Chief Exec. Officer of Leonardo
Mr. Christopher R. Anzalone Ph.D.